Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a small update to the page. This likely reflects back-end or formatting adjustments rather than changes to study data or eligibility details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating a new release of the page content or styling.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, representing a small backend/documentation update rather than a user-facing content change.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page shows a revision tag update from v3.6.2 to v3.6.3, indicating a new build or patch applied to the study details display.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a minor metadata update to the page and does not change the study details presented.SummaryDifference0.0%

- Check83 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has ended. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the revision label changed to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.